| Category | BioTech |
| Phone | 44-(0)28-7028-0022 |
| Employees |
| TOTAL | $366k |
| FUNDING TOTAL | $366k |
| Venture Round, 5/05 Invest Northern Ireland Enterprise Equity Limited Scottish Equity Partners | $366k |
Gendel has developed a unique, proprietary platform technology for the localised delivery of biological molecules to target sites within the body. Biopharmaceuticals may be loaded into the body’s own natural carrier system by a physical process and released at the target site in response to the application of non-invasive, low intensity ultrasound. Gendel’s technology may be employed for the delivery of a range of biological payloads including antibodies, enzymes, peptides, olionucleotides and DNA as well as carrier peptides and gene therapy vectors.
